Skip to content

Clinical application of targeted next generation sequencing(tNGS) in the etiological diagnosis of diarrhea in patients with hematological diseases

Clinical application of targeted next generation sequencing(tNGS) in the etiological diagnosis of diarrhea in patients with hematological diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074669
Enrollment
Unknown
Registered
2023-08-11
Start date
2023-08-12
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diarrhea

Interventions

Gold Standard:Stool cultures for bacteria and fungi
ELISA, PCR or Sanger sequencing for viruses
fecal smear for parasites.
Index test:targeted next generation sequencing(tNGS)

Sponsors

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) The subjects volunteered to join the study and signed the informed consent; 2) The subjects were diagnosed with hematological diseases; 3) The subjects defecated 3 or more times a day, and has abnormal stool characteristics (loose stool, watery stool, mucus stool, bloody stool, etc.), and the total stool volume exceeded 250g per day.

Exclusion criteria

Exclusion criteria: Subjects will be excluded if they have any of the following conditions: 1) Inability to provide written informed consent; 2) Subjects who received gastrointestinal surgery within the past 3 months; 3) Subjects who were diagnosed with inflammatory bowel disease (ulcerative colitis and Crohn's disease), intestinal malignancies, chronic pancreatitis, or pancreatic cancer; 4) Other concomitant diseases or other reasons that are not suitable for inclusion according to the judgment of the investigator.

Design outcomes

Primary

MeasureTime frame
targeted next generation sequencing(tNGS) ;Accuracy ;Sensitivity ;Specificity ;

Secondary

MeasureTime frame
Stool cultures for bacteria and fungi;Stool gram's stain;Stool viruses detection;fecal smear;

Countries

China

Contacts

Public ContactEllie Jiang

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences

jiangerlie@ihcams.ac.cn+86 151 2253 8106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026